Additionally, IGF-2 is significantly increased in the lung fibroblasts of IPF patients and promotes collagen and fibronectin deposition, and the blocking of endogenous IGF-2 or IGF-1R/IR expression inhibits extracellular matrix production. Here, IGF2 is linked to idiopathic pulmonary fibrosis.